石四药集团(02005.HK)获执行董事兼主席兼行政总裁曲继广增持88万股

Group 1 - The core point of the article is that Qu Jiguang, the Executive Director, Chairman, and CEO of China Pharmaceutical Group (stock code: 02005.HK), increased his shareholding by purchasing 880,000 shares at an average price of HKD 2.9652 per share, totaling approximately HKD 2.6094 million [1][2] - Following this transaction, Qu Jiguang's total shareholding increased to 1,169,862,000 shares, raising his ownership percentage from 39.61% to 39.64% [1][2]